BioHealth News Archive
Johns Hopkins Applied Physics Lab breaks ground on its biggest building yet – Technical.ly Baltimore
Johns Hopkins Applied Physics Lab is set to begin construction on a new building that will be the Laurel-based facility’s largest. {iframe}https://technical.ly/baltimore/2017/10/24/applied-physics-lab-building/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=57692417&_hsenc=p2ANqtz-921SPPkAjjE6lCJhx3RFsk6B0q3CphNxaJW4ck_NfnUbyTMOyxUplONKiTqwxQD7UZB1PiG_honzCs2Th8216H0-ESsQ&_hsmi=57692417{/iframe}
Read More
Entrepreneur Naveen Jain’s Newest Moonshot? Cure The Wo – Fast Company
Until recently, serial entrepreneur Naveen Jain’s most ambitious project was Moon Express, a literal moonshot that aims to land a rocket on our cratered…
Read More
University System of Maryland Encourages Researchers to Consider Benefits of Open Access to Their Works – USM
The University System of Maryland (USM) institutions have released a "Statement Supporting Open Access Dissemination of Scholarship," a joint statement created by the university…
Read More
Universities at Shady Grove’s Biomedical Sciences Center Building Project on Track for 2019 – Bethesda Beat – Bethesda, MD
Construction for the biomedical sciences building at the Universities at Shady Grove campus is on schedule, and county leaders are looking forward to landing…
Read More
JLABS Impact report – Johnson & Johnson Innovation
The JLABS: 5 Years of Innovation report quantifies the impact that JLABS and its companies have had on the innovation ecosystem during the past…
Read More
Brain Teasers: Researchers Say This Game Can Improve Brain Function
Want to boost your brain power? Researchers at Johns Hopkins think they have a solution. There are countless programs out there claiming to help…
Read More
CytImmune Sciences seeking to raise $2 million for a phase 2 trial of pancreatic cancer therapy – Baltimore Business Journal
The company is working on a therapy for pancreatic cancer using nanotechnology. {iframe}https://www.bizjournals.com/baltimore/news/2017/10/23/rockville-based-cancer-therapy-company-cytimmune.html{/iframe}
Read More
OpGen Awarded CDC Contract to Develop Clinical Support Tools for Antimicrobial Stewardship and Infection Control
OpGen, Inc. (NASDAQ:OPGN) today announced that it has been awarded a contract from the Centers for Disease Control and Prevention (CDC) to develop smartphone-based…
Read More
UM BioPark Named Outstanding Research Park of 2017 – University of Maryland, Baltimore
The University of Maryland BioPark was honored as the Outstanding Research Park of 2017 at the Association of University Research Parks (AURP) International Conference…
Read More
AGT Builds Montgomery County Gene & Cell Therapy Momentum – American Gene Technologies
American Gene Technologies (AGT), a private Maryland biotechnology company developing cures and treatments for Infectious diseases, cancers and monogenic disorders hosted a ribbon cutting…
Read More
TEDCO Selects Finalists for Incubation Challenge at 7th Annual Entrepreneur Expo – citybizlist
TEDCO today announced six finalists for its first-ever Incubator Challenge, a competition created to identify and reward the best ideas for supporting and growing…
Read More
United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso® Inhalation
United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA) of a new inhalation device, called the TD-300/A,…
Read More
Big data to lead Korea’s future biohealth sector
South Korea must swiftly work to build up a strong medical big data system as it will form the backbone of future medicine led…
Read More
Why the D.C. area’s tech incubators struggle – The Washington Post
When the District’s financially troubled 1776 incubator merged with an out-of-town counterpart recently, it became the latest star of Washington’s tech scene to fade…
Read More
FDA Approves GSK’s Shingles Vaccine with Agenus’ QS-21 Stimulon® Adjuvant | Markets Insider
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, announced today that the US Food and…
Read More